Schedule 13G ownership disclosure

Eton Pharmaceuticals Inc

Security class unavailable · CUSIP: 29772L108

Event date: 2018-11-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,249,329
Percent of class
7.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000899140-18-000602
Form type
SC 13G
Filer
APPEL PETER A
CIK
CIK 1227104
Filed
Nov 21, 2018
Reporting period
Nov 15, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub